November 22 | 2019

CORRECTION: 2cureX publishes interim report for the third quarter of 2019

Read more
November 22 | 2019

RÄTTELSE: 2cureX offentliggör delårsrapport för det tredje kvartalet 2019

Read more
November 22 | 2019

2cureX publishes interim report for the third quarter of 2019

Read more
November 22 | 2019

2cureX offentliggör delårsrapport för det tredje kvartalet 2019

Read more
November 6 | 2019

2cureX continues its efforts to ensure a strong IP protection for its IndiTreat test in the United States

Read more
November 6 | 2019

2cureX fortsätter sitt arbete med att säkra ett starkt IP-skydd för sitt IndiTreat-test i USA

Read more
October 15 | 2019

2cureX fortsätter sin IP-expansion genom säkrande av patent på sitt IndiTreat-test i Hong Kong

Read more
October 15 | 2019

2cureX continues its IP expansion by securing a patent on Its IndiTreat test in Hong Kong

Read more
October 8 | 2019

2cureX har ingått avtal med ett av de största privata cancersjukhusen i Norden

Read more
October 8 | 2019

2cureX has made an agreement with one of the largest private cancer hospitals in the Nordic countries

Read more
September 25 | 2019

2cureX Newsletter September 2019

Read more
September 25 | 2019

2cureX Newsletter September 2019

Read more
August 23 | 2019

2cureX offentliggör halvårsrapport för det första halvåret 2019

Read more
August 23 | 2019

2cureX publishes half-year report for the first half of 2019

Read more
July 23 | 2019

2cureX announces that patients are successfully being enrolled in the IndiTreat® pancreatic cancer trial

Read more
July 23 | 2019

2cureX meddelar att patienter framgångsrikt inkluderats i pankreascancerstudie med IndiTreat®

Read more
June 27 | 2019

Last day of trading in BTA 1 in 2cureX AB

Read more
June 27 | 2019

Sista dag för handel med BTA 1 i 2cureX AB

Read more